These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6100803)

  • 1. Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part I. Biology of tumour regression and recurrence.
    Tucker DF; Knight RA; Warne PH
    Clin Exp Metastasis; 1983; 1(3):261-73. PubMed ID: 6100803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part II. Sequential analysis of serum immune complexes and blocking activity in reconstituted mice in relation to tumour biology.
    Tucker DF; Knight RA; Warne PH
    Clin Exp Metastasis; 1983; 1(3):275-87. PubMed ID: 6100804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes.
    Cerundolo V; Zanovello P; McIntosh D; Fabbris R; Davies AJ; Collavo D
    Br J Cancer; 1987 Apr; 55(4):413-9. PubMed ID: 2437947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW
    Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth pattern of tumours in mice induced by murine Moloney sarcoma-virus and sarcoma-virus-transformed cells.
    Weiland F; Weiland E; Mussgay M
    Br J Cancer; 1979 Dec; 40(6):932-42. PubMed ID: 230854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell immunity to murine Moloney sarcoma virus-induced tumours: L3T4+ T cells are necessary for resistance to primary sarcoma growth, but Lyt-2+ T cells are required for resistance to secondary tumour cell challenge.
    Bateman WJ; Jenkinson EJ; Owen JJ
    Immunology; 1987 Jul; 61(3):317-20. PubMed ID: 2956180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated arrest and reversal of established visceral metastases in athymic mice.
    Wiltrout RH; Frost P; Morrison MK; Kerbel RS
    Cancer Res; 1979 Oct; 39(10):4034-41. PubMed ID: 476640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing and inhibiting effects of spleen cells from tumour-bearing mice on growth of virus-induced primary sarcoma.
    Kimura H; Aoki T
    Br J Cancer; 1978 Apr; 37(4):553-65. PubMed ID: 206273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocyte requirement for MSV tumour prevention or regression.
    Collavo D; Colombatti A; Chieco-Bianchi L
    Nature; 1974 May; 249(453):169-70. PubMed ID: 4545519
    [No Abstract]   [Full Text] [Related]  

  • 12. Some approaches to improve the therapeutic effectiveness of adoptive chemoimmunotherapy with spleen cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor.
    Weiskirch LM; Mokyr MB
    Int J Cancer; 1992 Apr; 51(1):84-92. PubMed ID: 1563847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.
    Zanovello P; Vallerani E; Biasi G; Landolfo S; Collavo D
    J Immunol; 1988 Feb; 140(4):1341-4. PubMed ID: 2830339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro demonstration of in situ autologous tumour-cell cytotoxicity in MSV-induced tumours in A/SN mice.
    Becker S; Haskill S
    Br J Cancer; 1981 Mar; 43(3):284-93. PubMed ID: 7053211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors.
    Gorczynski RM; Knight RA
    Eur J Immunol; 1975 Feb; 5(2):148-55. PubMed ID: 1086221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
    Boesen M; Svane IM; Engel AM; Rygaard J; Thomsen AR; Werdelin O
    Clin Exp Immunol; 2000 Aug; 121(2):210-5. PubMed ID: 10931133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.
    Keyaki A; Kuribayashi K; Sakaguchi S; Masuda T; Yamashita J; Handa H; Nakayama E
    Immunology; 1985 Sep; 56(1):141-51. PubMed ID: 3876272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against murine IFN-gamma abrogate in vivo tumor immunity against RSV-induced murine sarcomas.
    Prat M; Bretti S; Amedeo M; Landolfo S; Comoglio PM
    J Immunol; 1987 Jun; 138(12):4530-3. PubMed ID: 3035023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor.
    Weiskirch LM; Barker E; Mokyr MB
    Cancer Immunol Immunother; 1990; 31(3):129-38. PubMed ID: 2337902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.